NJ A3793 | 2016-2017 | Regular Session
Status
Sponsorship: Slight Partisan Bill (Democrat 6-2)
Status: Introduced on May 23 2016 - 25% progression, died in chamber
Action: 2016-10-20 - Substituted by S2024
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on May 23 2016 - 25% progression, died in chamber
Action: 2016-10-20 - Substituted by S2024
Text: Latest bill text (Introduced) [HTML]
Summary
Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
Title
Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
Sponsors
| Rep. Timothy Eustace [D] | Rep. Erik Peterson [R] | Rep. Herbert Conaway [D] | Sen. Raj Mukherji [D] |
| Rep. Daniel Benson [D] | Sen. Angela Mcknight [D] | Sen. Declan O'Scanlon [R] | Rep. Nancy Pinkin [D] |
Roll Calls
2016-10-06 - Assembly - Assembly Health and Senior Services Committee: Reported Favorably (Y: 11 N: 0 NV: 2 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2016-10-20 | Assembly | Substituted by S2024 |
| 2016-10-06 | Assembly | Reported out of Assembly Committee, 2nd Reading |
| 2016-05-23 | Assembly | Introduced, Referred to Assembly Health and Senior Services Committee |
Same As/Similar To
S2024 (Same As) 2016-12-05 - Approved P.L.2016, c.73.
